PRF: Consolidated Unaudited Interim Report of AS PRFoods

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
63
PRF: Consolidated Unaudited Interim Report of AS PRFoods for the 1st quarter and 3 months of 2019/2020 financial year

OVERVIEW OF ECONOMIC ACTIVITIES

PRFoods’ sales of 1st quarter 2019/2020 financial year was 19.3 million euros. Net profit 0.57 million euros, four times higher than Q3/2018. EBITDA 1.47 million euros, growth 31%.

MANAGEMENT COMMENTARY

We are happy to announce that based on the first quarter of the financial year (3rd quarter of 2019) the restructuring processes commenced within the Group during the last financial year, are demonstrating positive results.

The reporting period was characterized by a general decline in the prices of raw materials of fishery products, resulting in a fall in the prices of fish, fish fillets and smoked products. In spite of the approximately 5% price drop of the Group's main products, we were able to keep the total sales practically at the level of the last year. The third quarter sales for 2019 totalled 19.33 million euros (Q3 2018: 19.39 million euros).

The Group's consolidated EBITDA for the reporting period was 1.47 million euros, an increase of 31% compared to the same period last year, which was mainly affected by the gain from revaluation of biological assets by 0.85 million euros. Operating EBITDA (i.e. excluding one-offs and fish stock revaluation) was 0.73 million euros (Q3 2018: 1.06 million euros). Net profit was 0.57 million euros, almost four times higher than the net profit for the same period last year (Q3 2018: 0.14 million euros).

The Group's manufacturing and sales companies (Heimon Kala, John Ross Jr., Coln Valley Smokery, Trio Trading, Vettel) significantly improved their operational results compared to the same quarter last year; incl. exceeding the planned ones by ca 0.3 million euros in total. The decline in operating EBITDA compared to the previous year was attributable to the weaker performance of the Swedish fish farming unit (Överumans Fisk) due to the decline in the market price of fish, the recovery of which from its lowest level in the last three years is already noticeable.

We are optimistic about getting additional farming licences already in 2020. We will continue to make necessary preparations to increase the farming capacity which in turn would increase the quality raw material supply from our own Estonian fish farms.

PRFoods’ focus has been on improving cash flow from operating activities, which is reflected in Q3 2019 positive cash flow from operating activities in the amount of 1.3 million euros compared to 0.1 million euros in the same period last year. The Company's net debt was 19.9 million euros as at 30.09.2019 (30.09.2018: 21.9 million euros), which will decrease at the end of the year by repayments of investment loans and higher cash balance due to Christmas sales. As at 30.09.2019, the Group's working capital was negative by 3.0 million euros as current liabilities include liabilities to related parties in the amount of 4.1 million euros, which by their nature are long-term but due to accounting principles shall be reported as current.

We will continue to merge the business operations of the Estonian and Finnish companies and to create synergies, especially in product development and sales both in the domestic and export markets. The merger of the Finnish subsidiaries into one company is proceeding according to plan and Trio Trading Oy and Heimon Kala Oy will be merged into one company, which will continue under the name Heimon Kala Oy. In Estonia we have launched a Finnish-Estonian joint brand – Heimon Kala and for the first time in history we have successfully entered the local retail market with trout farmed in Saaremaa, Estonia.

Regarding the outbreak of listeria that hit the Estonian fishing industry, we can confirm that PRFoods companies have passed all additional controls successfully. The biggest role here is played by our internal quality and food safety controls in our companies, including the day-to-day controls in our own laboratories from the purchase of raw fish to the dispatch of the product from the factory.

The launch of John Ross Jr.'s renewed brand started at the end of the quarter and we expect significant growth in the UK market in the coming quarters.

In order to achieve our goals in the coming periods, the Group has engaged a strengthened management team of professionals. PRFoods team has done excellent job in developing our business and profitability. PRFoods’ balance sheet, production and customer base are strong, and we look optimistically towards future.

Big changes are always challenging for people in the company and I am very thankful that our team has enthusiastically embraced the changes and given their best.

KEY RATIOS

INCOME STATEMENT 

mln EUR 3Q 2019 2Q 2019 1Q 2019 4Q 2018 3Q 2018 2Q 2018 1Q 2018
Sales 19,3 21.5 18.1 26.7 19.4 22.1 22.7
Gross profit 2,6 2.1 2.1 4.7 3.0 1.8 2.4
EBITDA from operations 0,7 0.3 0.2 2.4 1.1 -0.2 0.7
EBITDA 1,5 0.3 -0.5 0.8 1.1 0.3 0.6
EBIT 1,0 -0.3 -1.0 0.2 0.6 -0.2 0.1
EBT 0,8 -0.4 -1.2 0.0 0.4 -0.5 -0.2
Net profit (-loss) 0,6 -0.6 -1.2 0.2 0.1 -1.1 -0.2
Gross margin 13,4% 9.8% 11.7% 17.7% 15.2% 7.9% 10.6%
Operational EBITDA margin 3,8% 1.4% 1.1% 9.1% 5.4% -1.1% 3.1%
EBITDA margin 7,6% 1.4% -2.5% 2.9% 5.8% 1.2% 2.5%
EBIT margin 5,0% -1.2% -5.6% 0.9% 3.0% -1.1% 0.2%
EBT margin 3,9% -2.0% -6.5% 0.1% 1.8% -2.3% -0.9%
Net margin 2,9% -3.0% -6.6% 0.8% 0.7% -5.1% -1.0%
Operating expense ratio 13,4% 11.7% 14.1% 11.2% 13.5% 12.0% 10.5%

BALANCE SHEET

mln EUR 30.09.2019 30.06.2019 31.03.2019 31.12.2018 30.09.2018 30.06.2018 31.03.2018
Net debt 19,9 20.5 18.7 20.0 21.9 18.1 16.7
Equity 22,8 21.9 23.3 24.2 24.1 23.3 24.3
Working capital -3,0 -3.1 -1.6 1.0 2.0 2.8 4.6
Assets 62,4 62.5 63.5 65.5 64.5 65.5 66.4
Liquidity ratio 0,9x 0.9x 0.9x 1.0x 1.1x 1.1x 1.2x
Equity ratio 36,5% 35.0% 36.7% 37.0% 37.4% 35.6% 36.6%
Gearing ratio 46,6% 48.3% 44.5% 45.2% 47.6% 43.7% 40.7%
Debt to total assets 0,6x 0.7x 0.6x 0.6x 0.6x 0.6x 0.6x
Net debt to EBITDA 5,4x 5.1x 5.4x 5.1x 3.8x 3.1x 2.6x
ROE -4,5% -6.5% -8.2% -4.0% 0.1% 0.2% 8.6%
ROA -1,6% -2.3% -3.0% -1.5% 0.0% 0.1% 4.1%

Consolidated Statement of Financial Position

Thousand euros 30.09.2019 30.09.2018 30.06.2019
ASSETS      
Cash and cash equivalents 2 327 2 788 2 583
Receivables and prepayments 3 941 4 219 5 300
Inventories 11 035 11 782 11 980
Biological assets 7 047 7 825 4 924
Total current assets 24 350 26 614 24 787
       
Deferred income tax 58 26 41
Long-term financial investments 202 134 202
Tangible fixed assets 14 536 14 528 14 535
Intangible assets 23 261 23 195 22 969
Total non-current assets 38 057 37 883 37 747
TOTAL ASSETS 62 407 64 497 62 534
       
EQUITY AND LIABILITIES      
Loans and borrowings 13 467 13 242 13 502
Payables 13 796 11 179 14 105
Government grants 126 242 234
Total current liabilities 27 389 24 663 27 841
       
Loans and borrowings 8 745 11 480 9 540
Payables 190 519 190
Deferred tax liabilities 2 192 2 426 2 010
Government grants 1 140 1 306 1 087
Total non-current liabilities 12 267 15 731 12 827
TOTAL LIABILITIES 39 656 40 394 40 668
       
Share capital 7 737 7 737 7 737
Share premium 14 007 14 007 14 007
Treasury shares -390 -390 -390
Statutory capital reserve 51 48 51
Currency translation reserve 30 31 -214
Retained profit (-loss) 636 2 004 66
Equity attributable to parent 22 071 23 437 21 257
Non-controlling interest 680 666 609
TOTAL EQUITY 22 751 24 103 21 866
TOTAL EQUITY AND LIABILITIES 62 407 64 497 62 534

Consolidated Statement of Profit or Loss And Other Comprehensive Income

Thousand euros 3Q 2019 3Q 2018 12m 2018/2019 12m 2017/2018
Sales 19 329 19 393 85,727 94,871
Cost of goods sold -16 747 -16 437 -73,830 -81,694
Gross profit 2 582 2 956 11,897 13,177
         
Operating expenses -2 598 -2 623 -10,702 -10,007
  Selling and distribution expenses -1 792 -1 843 -7,499 -7,125
  Administrative expenses -806 -780 -3,203 -2,882
Other income / expense 128 167 83 -162
Fair value adjustment on biological assets 846 73 -1,744 -674
Operating profit (loss) 958 573 -466 2,334
Financial income/-expenses -203 -222 -776 -936
Profit (loss) before tax 755 351 -1,242 1,398
Income tax -185 -209 -230 -399
Net profit (loss) for the period 570 142 -1,472 999
         
Net profit (loss) attributable to:        
Owners of the company 513 99 -1 458 1,001
Non-controlling interests 57 43 -14 -2
Total net profit (loss) 570 142 -1,472 999
         
Other comprehensive income (loss) that may subsequently be classified to profit or loss:        
Foreign currency translation differences 315 24 -221 -410
Total comprehensive income (expense) 885 166 -1,693 589
         
Total comprehensive income (expense) attributable to:        
Owners of the Company 828 123 -1 679 591
Non-controlling interests 57 43 -14 -2
Total comprehensive income (expense) for the period 885 166 -1 693 589
         
Profit (loss) per share (EUR) 0,02 0,00 -0,04 0,02
         
Diluted profit (loss) per share (EUR) 0,02 0,00 -0,04 0,02

Indrek Kasela

 AS PRFoods

 Member of the Management Board

 Phone: +372 452 1470

 investor@prfoods.ee

 www.prfoods.ee

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tampa General’s Innovation Excellence Earns No. 20 Spot

Updated Category News Views 7

A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...

Continue Reading
MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 3

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading
Wave Kids™ Unveils New Flavors for Kids' Drinks

Updated Category News Views 4

Sparking a Fresh Wave in the Kids' Beverage Market Alright, let me tell you about a new player plowing into the kids' drink scene. Wave Kids™, a brand that's making waves—pun intended—has a fresh lineup that screams 'fun' and 'healthy' in equal measure. Just coinciding with back-to-school season, this Scottsdale, Arizona outfit has rolled out not one or two, but...

Continue Reading
LeoLabs and SciTec Partner for $93.7M Space Force Deal

Updated Category News Views 2

LeoLabs and SciTec Join Forces for Space Dominance The space race ain't just about rockets blasting off anymore. It's about making sure we've got eyes everywhere, even on the back of our heads, so to speak. Enter LeoLabs teaming up with SciTec to help the U.S. Space Force upgrade their radar systems to something out of a sci-fi flick, armed with a $93.7 million contract...

Continue Reading
Midlife ADHD in Women: New Challenges and Solutions

Updated Category News Views 5

ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...

Continue Reading
Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Updated Category News Views 3

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 2

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading
Health Net's $2M Boost for Stanislaus Affordable Housing

Updated Category News Views 3

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

Continue Reading
Law Firm Gains Strength with Strategic New Hires

Updated Category News Views 1

Catching the latest twist in the legal scene, veteran criminal defense attorney John T. Floyd is stiffening the backbone of his Houston-based firm. Snagging both Christopher Choate and Mia Floyd, he's set to fortify his team representing folks caught in the snarl of Texas and federal criminal courts. New Faces, Massive Expertise Let's dig into Choate's credentials first....

Continue Reading
Veho's Role in Redefining Beauty E-Commerce Delivery

Updated Category News Views 2

Veho Grabs Headlines with BeautyMatter Awards Nod Here's something a bit off the beaten path: Veho's been tapping into new wells of opportunity in the e-commerce sector, and their latest accolade demonstrates just that. Named a finalist in the 2026 BeautyMatter Awards under the Logistics category, they're making noise in all the right circles. Beyond Boxes: Transforming...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative CyberKnife System Advances Treatment for CNS Tumors

Updated Category News Views 227

Introduction to the CyberKnife System Accuray Incorporated (NASDAQ: ARAY) has achieved remarkable advances in the treatment of central nervous system (CNS) tumors with its innovative CyberKnife System. This groundbreaking device stands at the forefront of precision radiation therapy, facilitating improvements in patient outcomes for many facing challenging diagnoses....

Continue Reading
Cango Inc. Reveals Key Insights into February Crypto Mining | CANG

Updated Category News Views 230

Cango Inc. Provides Update on Crypto Mining Operations Cango Inc. (NYSE: CANG), a prominent player in the automotive transaction service industry, has recently shared an important update regarding its foray into the crypto mining sector. This announcement sheds light on the company’s production figures and offers an overview of the operational metrics achieved during...

Continue Reading
Neumora Therapeutics: Key Updates and Investor Insights

Updated Category News Views 157

Understanding the Importance of Legal Counsel for Investors Investors, especially those within the biotech field, should be aware that legal advice can be a pivotal factor in protecting their interests. Neumora Therapeutics, Inc. (NASDAQ: NMRA) is currently involved in a securities class action that underlines this necessity. Neumora Therapeutics: An Overview Neumora...

Continue Reading
Getty Realty Corp. Reports Strong Second Quarter Growth

Updated Category News Views 86

Getty Realty Corp. Demonstrates Financial Strength in Latest Results Getty Realty Corp. (NYSE: GTY), a well-regarded net lease real estate investment trust (REIT) with a focus on convenience and automotive retail properties, has recently shared its financial outcomes for the quarter ending June 30, 2025. The company's progress is marked by a year-to-date investment...

Continue Reading
Sanara MedTech Welcomes Keith Myers to Board of Directors

Updated Category News Views 215

Sanara MedTech Announces Board Appointment FORT WORTH, TX -- Sanara MedTech Inc. (NASDAQ: SMTI), a pioneering name in medical technology dedicated to enhancing clinical outcomes, today revealed key changes to its Board of Directors. Sanara is recognized for its commitment to the surgical, chronic wound, and skincare markets, actively working to minimize healthcare...

Continue Reading